铝佐剂在儿童疫苗中的作用与安全性
本文综述铝盐作为疫苗佐剂近一个世纪的免疫学原理与安全性证据,指出药代动力学研究显示肌注疫苗释放的铝吸收缓慢并经肾脏有效清除,大规模临床与流行病学研究一致未发现其与孤独症谱系障碍、神经毒性、过敏性疾病或自身免疫病的关联。临床上铝佐剂疫苗一般不引起全身反应性,局部反应常见,证据支持其安全性及在部分疫苗中的必要性。
要点
- 铝盐佐剂增强疫苗免疫应答,近一个世纪使用中被绝大多数受种者良好耐受。
- 大规模临床与流行病学研究一致显示铝佐剂疫苗与孤独症谱系障碍、神经毒性、过敏及自身免疫病无关联。
- 临床以局部反应常见,全身反应性少见,可据此安抚照护者。
核心结论
- 证据强烈支持铝佐剂的安全性及其在部分疫苗中的必要性,其风险主要限于一过性局部反应,大规模临床与流行病学研究中无全身毒性信号。
研究设计与样本
- 本文为综述,总结铝佐剂的免疫学依据并评估所提出的安全性风险证据,未报告检索范围与样本量。
主要发现
- 药代动力学研究显示肌注疫苗释放的铝吸收缓慢并经肾脏有效清除,对全身铝水平的贡献很小。
- 大规模临床与流行病学研究一致表明铝佐剂疫苗与孤独症谱系障碍、神经毒性、过敏性疾病或自身免疫病无关联。
- 仅以铝盐为佐剂的疫苗临床上一般不引起全身反应性,但局部反应常见。
临床怎么用
- 临床医生可向照护者说明含铝疫苗获益明确,风险主要限于一过性局部反应,大规模研究中无全身毒性信号。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aluminum salts have been used as adjuvants in vaccines for nearly a century, enhancing the immune response to purified antigens and ensuring durable protection against serious infectious diseases. Despite their longstanding record of safety and effectiveness, aluminum adjuvants have become a focus of public concern, with claims linking them to developmental, neurologic, allergic, and autoimmune diseases. This review summarizes the immunologic rationale for aluminum adjuvants and evaluates the evidence for proposed safety risks. Aluminum salts have consistently been demonstrated over nearly a century of use to enhance the immune responses elicited by vaccines while also being well tolerated by nearly all who take them. Pharmacokinetic studies show that aluminum released from intramuscular vaccines is slowly absorbed and efficiently cleared by the kidneys, contributing minimally to systemic levels. Large-scale clinical and epidemiologic studies consistently demonstrate no association between aluminum-adjuvanted vaccines and autism spectrum disorder, neurotoxicity, allergic disease, or autoimmune disease. Clinically, vaccines adjuvanted solely with aluminum salts generally do not result in systemic reactogenicity, although local reactions are common. Collectively, the evidence strongly supports the safety of aluminum adjuvants and their necessity in certain vaccines. Clinicians can reassure caregivers that aluminum-containing vaccines provide clear benefits, with risks largely limited to transient local reactions and no systemic toxicity signal in large clinical and epidemiologic studies.
引用
- Nirenberg E, Maldonado YA, Hoffman SA, et al. The Role and Safety of Aluminum Adjuvants in Childhood Vaccines. Pediatrics. 2026. PMID: 41334965. doi:10.1542/peds.2025-074874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。